Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Plos One
|
June 9, 2017
Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation
Satoshi Yanagida, Michael S Anglesio, Tayyebeh M Nazeran, et al.
Fertility and Sterility
|
June 17, 2022
Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes
Teresa H Praetorius, Anna Leonova, Vivian Lac, et al.
Gynecologic Oncology
|
July 26, 2019
Molecular profiling and molecular classification of endometrioid ovarian carcinomas
Paulina Cybulska, Arnaud Da Cruz Paula, Jill Tseng, et al.
The Journal of Pathology
|
June 13, 2019
Oncogenic mutations in histologically normal endometrium: the new normal?
Vivian Lac, Tayyebeh M Nazeran, Basile Tessier-Cloutier, et al.
The Journal of Pathology. Clinical Research
|
March 28, 2023
KRAS mutations and endometriosis burden of disease
Natasha L Orr, Arianne Albert, Yang Doris Liu, et al.
Gynecologic Oncology
|
August 20, 2018
Histotype classification of ovarian carcinoma: A comparison of approaches
Lauren C Peres, Kara L Cushing-Haugen, Michael Anglesio, et al.
The New England Journal of Medicine
|
May 11, 2017
Cancer-Associated Mutations in Endometriosis without Cancer
Michael S Anglesio, Nickolas Papadopoulos, Ayse Ayhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2020
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
Pauline Krämer, Aline Talhouk, Mary Anne Brett, et al.
The Journal of Pathology
|
December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas
Karolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
British Journal of Cancer
|
June 20, 2020
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
Filipe Correia Martins, Dominique-Laurent Couturier, Anna Paterson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Plos One
|
June 9, 2017
Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation
Satoshi Yanagida, Michael S Anglesio, Tayyebeh M Nazeran, et al.
Fertility and Sterility
|
June 17, 2022
Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes
Teresa H Praetorius, Anna Leonova, Vivian Lac, et al.
Gynecologic Oncology
|
July 26, 2019
Molecular profiling and molecular classification of endometrioid ovarian carcinomas
Paulina Cybulska, Arnaud Da Cruz Paula, Jill Tseng, et al.
The Journal of Pathology
|
June 13, 2019
Oncogenic mutations in histologically normal endometrium: the new normal?
Vivian Lac, Tayyebeh M Nazeran, Basile Tessier-Cloutier, et al.
The Journal of Pathology. Clinical Research
|
March 28, 2023
KRAS mutations and endometriosis burden of disease
Natasha L Orr, Arianne Albert, Yang Doris Liu, et al.
Gynecologic Oncology
|
August 20, 2018
Histotype classification of ovarian carcinoma: A comparison of approaches
Lauren C Peres, Kara L Cushing-Haugen, Michael Anglesio, et al.
The New England Journal of Medicine
|
May 11, 2017
Cancer-Associated Mutations in Endometriosis without Cancer
Michael S Anglesio, Nickolas Papadopoulos, Ayse Ayhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 2, 2020
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
Pauline Krämer, Aline Talhouk, Mary Anne Brett, et al.
The Journal of Pathology
|
December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas
Karolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
British Journal of Cancer
|
June 20, 2020
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
Filipe Correia Martins, Dominique-Laurent Couturier, Anna Paterson, et al.
Page
of 2